Skip to search.
 NZX 50 Up 0.36%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
12.80 Up 0.02(0.16%) 06:14 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:12.78
Open:12.71
Bid:12.75 x 400
Ask:12.76 x 500
1y Target Est:24.25
Beta:5.99
Earnings Date:6 May - 11 May (Est.)
Day's Range:12.60 - 12.96
52wk Range:10.85 - 18.48
Volume:597,844
Avg Vol (3m):1,742,300
Market Cap:1.33b
P/E (ttm):N/A
EPS (ttm):-1.23
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KERXUp 0.16%1.33b
BAXUp 0.53%37.10b
SHPGUp 1.53%47.37b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):122.31
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.94
Quarterly EPS Est (Mar-15) :-0.29
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.13

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback